Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 154 - 174Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Baseler, L, Chertow, DS, Johnson, KM, et al. The pathogenesis of Ebola virus disease. Annu Rev Pathol 2017; 12: 387.Google Scholar
Bouree, P, Bergman, J-F. Ebola virus infection in man. Am J Trop Med Hyg 1983; 32: 1465.CrossRefGoogle ScholarPubMed
CDC documents: www.cdc.gov/ebola.Google Scholar
Howard, CR. Viral hemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Res 1984; 4: 169.Google Scholar
Kiiza, P, Mullin, S, Teo, K, et al. Treatment of Ebola-related critical illness. Intens Care Med 2020; 46: 285.CrossRefGoogle ScholarPubMed
Leroy, EM, Kumulunqui, B, Pourrut, X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438: 575.CrossRefGoogle Scholar
Leroy, EM, Rouquet, P, Formenty, P, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 2004; 303: 387.Google Scholar
Li, YH, Chen, SP. Evolutionary history of Ebola virus. Epidemiol Infect 2014; 142: 1138.Google Scholar
Martin, P, Laupland, KB, Frost, EH, et al. Laboratory diagnosis of Ebola virus disease. Intens Care Med 2015; 41: 895.Google Scholar
Mulangu, S, Dodd, LE, Davey, RT, et al. A randomized controlled trial of Ebola virus disease therapeutics. N Engl J Med 2019; 381: 2293.Google Scholar
Parkes-Ratanshi, R, Ssekabira, U, Crozier, I. Ebola in West Africa: be aware and prepare. Intens Care Med 2014; 40: 1742.Google Scholar
Sanchez, A, Ksiazek, TG, Rollin, PE, et al. Reemergence of Ebola virus in Africa. Emerg Infect Dis 1995; 1: 3.Google Scholar
Suresh, V. The enigmatic haemorrhagic fevers. J R Soc Med 1997; 90: 622.CrossRefGoogle ScholarPubMed
Tattevin, P, Durante-Mangoni, E, Massaquoi, M. Does this patient have Ebola virus disease? Intens Care Med 2014; 40: 1738.CrossRefGoogle ScholarPubMed
Bibliography
Eckert, J, Deplazes, P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107.Google Scholar
Kammerer, WS, Schantz, PM. Echinococcal disease. Infect Dis Clin North Am 1993; 7: 605.CrossRefGoogle ScholarPubMed
McCullagh, PJ. Hydatid disease: medical problems, veterinary solutions, political obstacles. Med J Aust 1996; 164: 7.CrossRefGoogle ScholarPubMed
McManus, DP, Zhang, W, Li, J, et al. Echinococcosis. Lancet 2003; 362: 1295.CrossRefGoogle ScholarPubMed
Bibliography
Greene, SL, Su, WP, Muller, SA. Ecthyma gangrenosum. J Am Acad Dermatol 1984; 11: 781.Google Scholar
Hirschmann, JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Mallette, LE. The parathyroid polyhormones: new concepts in the spectrum of peptide hormone action. Endocr Rev 1991; 12: 110.CrossRefGoogle ScholarPubMed
Bibliography
Borow, KM, Karp, R. Atrial septal defect: lessons from the past, directions for the future. N Engl J Med 1990; 323: 1698.Google Scholar
Nora, JJ. Causes of congenital heart disease: old and new modes, mechanisms, and models. Am Heart J 1993; 125: 1409.Google Scholar
Wilson, NJ, Neutze, JM. Adult congenital heart disease: principles and management guidelines. Aust NZ J Med 1993; 23: 498 & 697.Google Scholar
Bibliography
Britton, PN, Eastwood, K, Brew, BJ, et al. Consensus guidelines for the investigation and management of encephalitis. Med J Aust 2015; 202: 576.Google Scholar
Burrow, JNC, Whelan, PI, Kilburn, CJ, et al. Australian encephalitis in the Northern Territory: clinical and epidemiological features, 1987–1996. Aust NZ J Med 1998; 28: 590.CrossRefGoogle ScholarPubMed
Dalmau, J, Gleichman, AJ, Hughes, EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091.CrossRefGoogle ScholarPubMed
Dalmau, J, Graus, F. Antibody-mediated encephalitis. N Engl J Med 2018; 378: 840.CrossRefGoogle ScholarPubMed
Ho, KM. Use of tramadol to attenuate severe dyskinesia in anti-N-methyl-D-aspartate receptor encephalitis. Anaesth Intens Care 2010; 47: 561.CrossRefGoogle Scholar
Honarmand, S, Glaser, CA, Chow, E, et al. SSPE in the differential diagnosis of encephalitis. Neurology 2004; 63: 1489.Google Scholar
Knox, J, Cowan, RU, Doyle, JS, et al. Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust 2012; 196: 322.Google Scholar
Meyfroidt, G, Kurtz, P, Sonneville, R. Critical care management of infectious meningitis and encephalitis. Intens Care Med 2020; 46: 192.Google Scholar
Neyens, RR, Gaskill, GE, Chalela, JA. Critical care management of anti-N-methyl-D-aspartate receptor encephalitis. Crit Care Med 2018; 46: 1514.Google Scholar
Sonneville, R, Venkatesan, A, Honnorat, J. Understanding auto-immune encephalitis in the ICU. Intens Care Med 2019; 45: 1795.CrossRefGoogle ScholarPubMed
Varvat, J, Lafond, P, Page, Y, et al. Acute psychiatric syndrome leading young patients to ICU: consider anti-NMDA-receptor antibodies. Anaesth Intens Care 2010; 38: 748.CrossRefGoogle ScholarPubMed
Bibliography
Bolton, CF, Young, GB, Zochodne, DW. The neurological complications of sepsis. Ann Neurol 1993; 33: 94.Google Scholar
Brooks, BR, Walker, DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2: 299.Google Scholar
Celesia, GG, Grigg, MM, Ross, E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988; 45: 781.CrossRefGoogle ScholarPubMed
Edgren, E, Hedstrand, U, Kelsey, S, et al. Assessment of neurological prognosis in comatose survivors of cardiac arrest. Lancet 1994; 343: 1055.Google Scholar
Fraser, CL, Arieff, AI. Nervous system complications in uremia. Ann Intern Med 1988; 109: 143.Google Scholar
Bibliography
Alpert, JS, Krous, HF, Dalen, JE, et al. Pathogenesis of Osler’s nodes. Ann Intern Med 1976; 85: 471.Google Scholar
Bayer, AS, Bolger, AF, Taubert, KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98: 2936.Google Scholar
Calderwood, SB, Swinski, LA, Karchmer, AW, et al. Prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1986; 92: 776.CrossRefGoogle Scholar
Chambers, JB, Shanson, D, Hall, R, et al. Antibiotic prophylaxis of endocarditis: the rest of the world and NICE. J R Soc Med 2011; 104: 138.Google Scholar
Dajani, AS, Taubert, KA, Wilson, W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277: 1794.CrossRefGoogle ScholarPubMed
Houpikian, P, Raoult, D. Diagnostic methods: current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Cardiol Clin 2003; 21: 207.Google Scholar
Kaye, D. Changing pattern of infective endocarditis. Am J Med 1985; 79 (suppl. 6B): 157.Google Scholar
Lerner, PI, Weinstein, L. Infective endocarditis in the antibiotic era. N Engl J Med 1966; 274: 199, 259, 323 & 388.CrossRefGoogle ScholarPubMed
Levin, HJ, Paulker, SG, Salzman, EW, et al. Antithrombotic therapy in valvular heart disease. Chest 1992; 102: S434.Google Scholar
Liesenborghs, L, Meyers, S, Vanassche, T, et al. Coagulation: at the heart of infective endocarditis. J Thromb Haemost 2020; 18: 995.Google Scholar
Mansur, AJ, Grinberg, M, Lemos da Luz, P, et al. The complications of infective endocarditis. Arch Intern Med 1992; 152: 2428.Google Scholar
O’Gara, PT. Infective endocarditis. In: Scientific American Medicine. Infectious Diseases. Hamilton: Dekker Medicine. 2020.Google Scholar
Stein, PD, Alpert, JS, Copeland, J, et al. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1992; 102: S445.Google Scholar
Tornos, P, Almirante, B, Olona, M, et al. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis 1997; 24: 381.Google Scholar
Tunkel, AR, Kaye, D. Endocarditis with negative blood cultures. N Engl J Med 1992; 326: 1215.Google Scholar
Wilson, W, Taubert, KA, Gewitz, M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation 2007; 116: 1736.Google Scholar
Wolff, M, Mourvillier, B, Sonnerville, R, et al. My paper 10 years later: infective endocarditis in the intensive care unit. Intens Care Med 2014; 40: 1843.Google Scholar
Yau, JWY, Lee, P, Wilson, A, et al. Prosthetic valve endocarditis: what is the evidence for anticoagulant therapy? Intern Med J 2011; 41: 795.Google Scholar
Bibliography
Berl, T. Treating hyponatremia: damned if we do and damned if we don’t. Kidney Int 1990; 37: 1006.Google Scholar
Chernow, B, ed. The Pharmacological Approach to the Critically Ill Patient. 3rd edition. Baltimore: Williams & Wilkins. 1994.Google Scholar
Chrousos, GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351.Google Scholar
Curry, SC, Arnold-Capell, P. Nitroprusside, nitroglycerin, and angiotensin-converting enzyme inhibitors. Crit Care Clin 1991; 7: 555.Google Scholar
Deane, A, Chapman, MJ, Fraser, RJL, et al. Bench-to-bedside: the gut as an endocrine organ in the critically ill. Crit Care 2010; 14: 228.CrossRefGoogle Scholar
Editorial. Corticosteroids and hypothalamic-pituitary-adrenocortical function. BMJ 1980; 280: 813.Google Scholar
Ekins, R. The free hormone hypothesis and measurement of free hormones. Clin Chem 1992; 38: 1289.Google Scholar
Grinspoon, SK, Bilezikian, JP. HIV disease and the endocrine system. N Engl J Med 1992; 327: 1360.Google Scholar
Ligtenberg, JJM, Girbes, ARJ, Beentjes, JAM, et al. Hormones in the critically ill patient: to intervene or not to intervene? Intens Care Med 2001; 27: 1567.Google Scholar
McMahon, GT, Dluhy, RG. Approach to the patient with endocrine disorders. In: Scientific American Medicine. Endocrinology & Metabolism. Hamilton: Dekker Medicine. 2020.Google Scholar
Melmed, S, Koenig, R, Rosen, C, et al., eds. Williams Textbook of Endocrinology. 14th edition. Philadelphia: Elsevier. 2019.Google Scholar
Oster, JR, Singer, I, Fishman, LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 1995; 98: 575.Google Scholar
Rose, BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81: 1033.Google Scholar
Salem, M, Tainsh, RE, Bromberg, J, et al. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994; 219: 416.Google Scholar
Tonner, DR, Schlechte, JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am 1993; 77: 251.Google Scholar
Bibliography
Parikh, HG, Miller, A, Chapman, M, et al. Calorie delivery and clinical outcomes in the critically ill: a systematic review and meta-analysis. Crit Care Resusc 2016; 18: 17.Google Scholar
Phelan, G. Determination of energy expenditure. In: Scientific American Medicine. Nutrition. Hamilton: Dekker Medicine. 2020.Google Scholar
Taylor, BE, McClave, SA, Martindale, RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (ASPEN). Crit Care Med 2016; 44: 390.Google Scholar
Bibliography
Blaser, MJ, Smith, PD, Ravdin, JL, et al., eds. Infections of the Gastrointestinal Tract. 2nd edition. New York: Raven Press. 2002.Google Scholar
Hellard, ME, Fairley, CK. Gastroenteritis in Australia: who, what, where, and how much? Aust NZ J Med 1997; 27: 147.Google Scholar
Phillips, SF. Diarrhea: a current view of the pathophysiology. Gastroenterology 1972; 63: 495.Google Scholar
Schlager, TA, Guerrant, RL. Seven possible mechanisms for Escherichia coli diarrhea. Infect Dis Clin North Am 1988; 2: 607.Google Scholar
Slutsker, L, Ries, AA, Greene, KD, et al. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 1997; 126: 505.Google Scholar
Wong, CS, Jelacic, S, Habeeb, RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157-H7 infections. N Engl J Med 2000; 342: 1930.Google Scholar
Bibliography
American College of Physicians. Occupational and environmental medicine: the internist’s role. Ann Intern Med 1990; 113: 974.Google Scholar
Bascom, R, Bromberg, PA, Costa, DL, et al. Health effects of outdoor pollution. Am J Respir Crit Care Med 1996; 153: 3 & 477.Google Scholar
Nriagu, JO, Pacyna, JM. Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1988; 333: 134.Google Scholar
Rosenstock, L, Cullen, M, Brodkin, CA, et al., eds. Textbook of Clinical Occupational and Environmental Medicine. 2nd edition. Philadelphia: Saunders. 2005.Google Scholar
Roxe, DM, Krumlovsky, FA. Toxic interstitial nephropathy from metals, metabolites, and radiation. Semin Nephrol 1988; 8: 72.Google Scholar
Bibliography
Fauci, A, Harley, J, Roberts, W, et al. The idiopathic hypereosinophilic syndrome. Ann Intern Med 1982; 97: 278.Google Scholar
Gleich, GJ, Loegering, DA. Immunobiology of eosinophils. Annu Rev Immunol 1984; 2: 429.Google Scholar
Kalac, M, Quintas-Cardama, A, Vrhovac, R, et al. A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia. Cancer 2007; 110: 955.Google Scholar
Kita, H. The eosinophil: a cytokine-producing cell? J Allergy Clin Immunol 1996; 97: 889.Google Scholar
Salter, BM, Sehmi, R. Hematopoietic processes in eosinophilic asthma. Chest 2017; 152: 410.Google Scholar
Bibliography
Allen, JN, Davis, WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150: 1423.Google Scholar
Allen, JN, Magro, CM, King, MA. The eosinophilic pneumonias. Semin Respir Crit Care Med 2002; 23: 127.Google Scholar
Janz, DR, O’Neal, HR, Ely, EW. Acute eosinophilic pneumonia: a case report and review of the literature. Crit Care Med 2009; 37: 1470.Google Scholar
Jederlinic, PJ, Sicilian, L, Gaensler, EA. Chronic eosinophilic pneumonia: a report of 19 cases and a review of the literature. Medicine 1988; 67: 154.Google Scholar
Johkoh, T, Muller, NL, Akira, M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000; 216: 773.CrossRefGoogle ScholarPubMed
Naughton, M, Fahy, J, FitzGerald, MX. Chronic eosinophilic pneumonia. Chest 1993; 103: 162.Google Scholar
Ricketti, AJ, Greenberger, PA, Mintzer, RA, et al. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143: 1553.Google Scholar
Rosenberg, CE, Khoury, R. Approach to eosinophilia presenting with pulmonary symptoms. Chest 2021; 159: 507.Google Scholar
Salter, BM, Sehmi, R. Hematopoietic processes in eosinophilic asthma. Chest 2017; 152: 410.Google Scholar
Schatz, M, Wasserman, S, Patterson, R. Eosinophils and immunologic lung disease. Med Clin North Am 1981; 65: 1055.Google Scholar
Bibliography
Fine, J-D. Epidermolysis bullosa: clinical aspects, pathology, and recent advances in research. Int J Dermatol 1986; 25: 143.Google Scholar
Bibliography
Baker, AS, Ojemann, RG, Swartz, MN, et al. Spinal epidural abscess. N Engl J Med 1975; 293: 463.Google Scholar
Bibliography
Tynell, E, Aurelius, E, Brandell, A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996; 174: 324.Google Scholar
Bibliography
Ogilvie, CM, Milsom, SR. Dopamine agonists in the treatment of prolactinoma: are they still first choice? Intern Med J 2011; 41: 156.Google Scholar
Redfield, MM, Nicholson, WJ, Edwards, WD, et al. Valve disease associated with ergot alkaloid use. Ann Intern Med 1992; 117: 50.Google Scholar
Bibliography
Eriksson, B, Jorup-Ronstrom, C, Karkkoonen, K, et al. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996; 23: 1091.Google Scholar
Hirschmann, JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Auquier-Dunant, A, Mockenhaupt, M, Naldi, L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019.Google Scholar
Struck, MF, Hilbert, P, Mockenhaupt, M, et al. Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intens Care Med 2010; 36: 22.Google Scholar
Bibliography
Corwin, HL, Gettinger, A, Fabian, TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007; 357: 965.Google Scholar
Henry, DH, Spivak, JL. Clinical use of erythropoietin. Curr Opinion Hematol 1995; 2: 118.Google Scholar
Krafte-Jacobs, B, Levetown, ML, Bray, GL, et al. Erythropoietin responses to critical illness. Crit Care Med 1994; 22: 821.Google Scholar
Litton, E, Latham, P, Inman, J, et al. Safety and efficacy of erythropoiesis-stimulating agents in critically ill patients admitted to the intensive care unit: a systematic review and meta-analysis. Intens Care Med 2019; 45: 1190.Google Scholar
Nichol, A, French, C, Little, L, et al. Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. Lancet 2015; 386: 2499.Google Scholar
Bibliography
Barceloux, DG, Krenzelok, EP, Olson, K, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of ethylene glycol poisoning. J Toxicol Clin Toxicol 1999; 37: 537.Google Scholar
Brent, J, McMartin, K, Phillips, S, et al. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med 1999; 340: 832.Google Scholar
DaRoza, R, Henning, RI, Sunshine, I, et al. Acute ethylene glycol poisoning. Crit Care Med 1984; 12: 103.Google Scholar
Hantson, Ph, Hassoun, A, Mahieu, P. Ethylene glycol poisoning treated by intravenous 4-methylpyrazole. Intens Care Med 1998; 24: 736.Google Scholar
Jacobsen, D, McMartin, KE. Methanol and ethylene glycol poisoning: mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol 1986; 1: 309.Google Scholar
Jacobsen, D, McMartin, KE. Antidotes for methanol and ethylene glycol poisoning. J Toxicol Clin Toxicol 1997; 35: 127.Google Scholar
Karlson-Stiber, C, Persson, H. Ethylene glycol poisoning: experience from an epidemic in Sweden. J Toxicol Clin Toxicol 1992; 30: 565.Google Scholar
Kulig, K, Duffy, JP, Lenden, CH, et al. Toxic effects of methanol, ethylene glycol and isopropyl alcohol. Topics in Emerg Med 1984; 6: 14.Google Scholar
Megarbane, B, Borron, SW, Baud, FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intens Care Med 2005; 31: 189.Google Scholar
Megarbane, B, Borron, SW, Trout, H, et al. Treatment of acute methanol poisoning with fomepizole. Intens Care Med 2001; 27: 1370Google Scholar
Mokhlesi, B, Leikin, JB, Murray, P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest 2003; 123: 897.Google Scholar
Shannon, M. Toxicology reviews: fomepizole - a new antidote. Pediatr Emerg Care 1998; 14: 170.Google Scholar
Zimmerman, JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794.Google Scholar
Bibliography
Berger, MM, Reymond, MJ, Shenkin, A, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis. Intens Care Med 2001; 27: 91.Google Scholar
Docter, R, Krenning, EP, De Jong, M, et al. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993; 39: 499.Google Scholar
Kaptein, EM, Spencer, CA, Kamiel, MB, et al. Prolonged dopamine administration and thyroid hormone economy in normal and critically ill subjects. J Clin Endocrinol Metab 1980; 51: 387.Google Scholar
Ramsay, I. Drug and non-thyroid induced changes in thyroid function tests. Postgrad Med J 1985; 61: 375.Google Scholar
Surks, MI, Chopra, IJ, Mariash, CN, et al. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990; 263: 1529.Google Scholar
Wartofsky, L, Burman, KD. Alterations in thyroid function in patients with systemic illness: ‘The euthyroid sick syndrome’. Endocrinol Rev 1982; 3: 164.Google Scholar
Young, R, Worthley, LIG. Diagnosis and management of thyroid disease and the critically ill patient. Crit Care Resusc 2004; 6: 295.Google Scholar
Bibliography
Auquier-Dunant, A, Mockenhaupt, M, Naldi, L, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002; 138: 1019.Google Scholar
Gerull, R, Nelle, M, Schaible, T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med 2011; 39: 1521.Google Scholar
Kim, P, Goldfarb, P, Gaisford, T, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis. J Burn Care Rehabil 1983; 4: 93.Google Scholar
Lin, M-S, Dai, Y-S, Pwu, R-F, et al. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis. Intern Med J 2005; 35: 188.Google Scholar
Lyell, A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol 1967; 79: 662.Google Scholar
Melish, ME, Glasgow, LA, Turner, MD. The staphylococcal scalded-skin syndrome: isolation and partial purification of the exfoliative toxin. J Infect Dis 1972; 125: 129.Google Scholar
Nicolis, GD, Helwig, EB. Exfoliative dermatitis: a clinicopathologic study of 135 cases. Arch Dermatol 1973; 108: 788.Google Scholar
Roujeau, JC, Kelly, JP, Naldi, L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600.Google Scholar
Sehgal, VN, Gangwani, OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67.Google Scholar
Stanley, JR, Amagai, M. Pemphigus, bullous impetigo and staphylococcal scalded skin syndrome. N Engl J Med 2006; 355: 1800.Google Scholar
Struck, MF, Hilbert, P, Mockenhaupt, M, et al. Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intens Care Med 2010; 36: 22.Google Scholar
Thestrup-Pedersen, K, Halkier-Sorensen, L, Sogaard, H, et al. The red man syndrome: exfoliative dermatitis of unknown etiology. J Am Acad Dermatol 1988; 18: 1307.Google Scholar
Wolff, K, Tappeiner, G. Treatment of toxic epidermal necrolysis. Arch Dermatol 2003; 139: 85.Google Scholar